MissionIR Articles

VistaGen Therapeutics is focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. The idea is to generate new…

Moments ago, a Form 4 was filed with the SEC reporting that Shawn K. Singh, J.D., Chief Executive Officer of VistaGen Therapeutics, acquired 100,000 shares of the company at $0.50. Mr. Singh now holds 252,174…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced its membership in the Toronto-based Centre for Commercialization of Regenerative Medicine’s (CCRM) Industry Consortium. “VistaGen’s…

Recently, when Bristol-Myers Squibb was forced to suspend testing of its pill for hepatitis C because one of the patients suffered heart failure, it was a major blow to the pharmaceutical giant. Bristol had spent…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening, today announced a significant advance in its development of LiverSafe 3D™, a human liver cell-based bioassay system…

The idea of a turnaround is often associated with dysfunctional companies being purchased by outsiders or otherwise given new management, and then being transformed with a change in product, structure, or philosophy, providing a fresh…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that results of their collaboration with Duke University were presented this week at the American…

VistaGen Therapeutics, the rapidly evolving biotech firm that is advancing a stem cell-based technology platform focused on controlling pluripotent stem cell differentiation for application in drug rescue initiatives and next generation pharmaceutical assays for testing…

VistaGen Therapeutics, a biotechnology company applying human pluripotent stem cell technology for drug rescue and novel pharmaceutical assays, just announced the completion of the previously announced $3.25 million financing commitment with Platinum Long Term Growth…

VistaGen Therapeutics is best known for having developed a versatile stem cell technology platform which can be used to produce superior testing options for new drug candidates, with the potential of saving the drug industry…

South San Francisco, California-based VistaGen Therapeutics has developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into multiple types of mature, non-transformed cells, as a source for…

The pharmaceutical industry has invested billions of dollars developing drugs that can do truly amazing things once they are successfully applied. However, one of the historic challenges faced by the healthcare industry has been to…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue and novel pharmaceutical assays for predictive heart and liver toxicology and drug metabolism screening, announced that Platinum Long Term Growth VII, LLC purchased…

A report in PharmaTimes online points to a report from Fitch Ratings, one of the Big Three credit rating agencies, warning that the U.S. Food and Drug Administration (FDA) will approve fewer novel drugs in…

VistaGen is known best for its proprietary stem cell technology used in their novel bioassay systems to provide superior toxicity testing of new drug candidates. The company’s Human Clinical Trials in a Test TubeTM platform…

VistaGen Therapeutics is a biotechnology company focused primarily on the use of its proprietary pluripotent stem cell technology to discover, rescue, and develop novel drug candidates for a wide range of diseases. For those unfamiliar…

The understanding and mastery of human stem cells has grown into a major industry. It is becoming increasingly clear that stem cells play an ongoing and vital role in the human body, and knowing how…

VistaGen has developed a unique and versatile stem cell technology platform with a number of applications. The platform itself is based upon the controlled differentiation of human pluripotent stem cells into mature non-transformed cells. These…

VistaGen is best known for its development of technologies that could revolutionize the testing of new drug candidates, potentially saving pharmaceutical companies billions of dollars by helping them select the most promising drug development opportunities…

VistaGen, developer of stem cell technologies for improved drug testing, has emphasized that using stem cell-based bioassay systems could save pharmaceutical developers tremendous amounts of money through the use of accurate early drug testing. It…